Physician profile
Patrick Buchanan
NPI 1578865416
$5,109.11
in general payments reported to CMS, 2019-2025
14 companies · $568 in 2025
The $568 reported for 2025 was more than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $935 · 2021: $806 · 2022: $1,583 · 2023: $833 · 2024: $384 · 2025: $568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,785.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,302.53 | 2022 | |
| Cochlear Americas | $921.98 | 2019-2025 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Med-El Corporation | $820.26 | 2019-2024 | Bci 602 Kit, Mi1250 Synchrony 2 Flexsoft |
| Painteq LLC | $725.61 | 2022-2023 | Painteq |
| Inspire Medical Systems, INC. | $701.72 | 2021-2025 | Inspire |
| Intersect Ent, INC. | $142.60 | 2021 | |
| Vertos Medical, INC. | $138.46 | 2024 | Mild Device Kit |
| Medtronic USA, INC. | $110.53 | 2019 | |
| Axogen | $75.92 | 2019 | |
| Stryker Corporation | $60.76 | 2025 | Core, Shaver System |
| Medtronic, INC. | $36.51 | 2024 | Quadcut |
| Oticon Medical, LLC | $27.20 | 2025 | Ponto Bone Anchored Hearing System |
| Glaxosmithkline, LLC. | $24.65 | 2025 | Nucala |
| Alk-Abello, INC | $20.38 | 2023 | Odactra, Ragwitek, Grastek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Buchanan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.